Expression ofTRAILand Its Receptors in Human Brain Tumors
- 1 April 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 257 (2) , 454-459
- https://doi.org/10.1006/bbrc.1999.0493
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Death Receptors: Signaling and ModulationScience, 1998
- TRAIL/Apo-2-ligand-induced apoptosis in human T cellsEuropean Journal of Immunology, 1998
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor geneNature Genetics, 1997
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- Caspases: killer proteasesTrends in Biochemical Sciences, 1997
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997
- Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?Journal of Clinical Investigation, 1997
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995